Keay Nakae
Stock Analyst at Chardan Capital
(2.99)
# 1,405
Out of 4,876 analysts
233
Total ratings
29.69%
Success rate
3.8%
Average return
Main Sectors:
Stocks Rated by Keay Nakae
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IBIO iBio, Inc. | Maintains: Buy | $5 | $0.69 | +629.93% | 5 | Jun 25, 2025 | |
| MNPR Monopar Therapeutics | Initiates: Buy | $60 | $35.01 | +71.38% | 1 | Jun 23, 2025 | |
| DYN Dyne Therapeutics | Maintains: Buy | $50 | $10.00 | +400.00% | 12 | Jun 17, 2025 | |
| SLN Silence Therapeutics | Maintains: Buy | $35 | $5.52 | +534.06% | 12 | Jun 13, 2025 | |
| RNA Avidity Biosciences | Maintains: Buy | $65 → $75 | $29.97 | +150.29% | 17 | Jun 9, 2025 | |
| SABS SAB Biotherapeutics | Maintains: Buy | $20 | $1.78 | +1,023.60% | 15 | May 15, 2025 | |
| OBIO Orchestra BioMed Holdings | Maintains: Buy | $20 | $3.06 | +553.59% | 10 | May 13, 2025 | |
| KRRO Korro Bio | Maintains: Buy | $25 | $12.34 | +102.59% | 2 | May 13, 2025 | |
| COYA Coya Therapeutics | Maintains: Buy | $14 | $5.89 | +137.69% | 18 | May 13, 2025 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Buy | $60 | $16.13 | +271.98% | 19 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $1.25 → $6 | $9.40 | -36.17% | 10 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $300 → $325 | $316.75 | +2.60% | 13 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 | $1.16 | +1,624.14% | 14 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 | $1.93 | +210.88% | 7 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 | $3.19 | +56.74% | 12 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $2.5 | $2.50 | - | 6 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 | $2.21 | +81.00% | 14 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $8 | $0.98 | +716.33% | 10 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.22 | - | 5 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $8 → $6 | $10.75 | -44.19% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $20 | $0.47 | +4,118.52% | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $55 | $6.77 | +712.41% | 10 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.25 → $10 | $5.55 | +80.34% | 5 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $100 → $88 | $11.41 | +666.87% | 2 | Sep 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $0.7 → $13 | $1.05 | +1,138.10% | 3 | Feb 9, 2021 |
iBio, Inc.
Jun 25, 2025
Maintains: Buy
Price Target: $5
Current: $0.69
Upside: +629.93%
Monopar Therapeutics
Jun 23, 2025
Initiates: Buy
Price Target: $60
Current: $35.01
Upside: +71.38%
Dyne Therapeutics
Jun 17, 2025
Maintains: Buy
Price Target: $50
Current: $10.00
Upside: +400.00%
Silence Therapeutics
Jun 13, 2025
Maintains: Buy
Price Target: $35
Current: $5.52
Upside: +534.06%
Avidity Biosciences
Jun 9, 2025
Maintains: Buy
Price Target: $65 → $75
Current: $29.97
Upside: +150.29%
SAB Biotherapeutics
May 15, 2025
Maintains: Buy
Price Target: $20
Current: $1.78
Upside: +1,023.60%
Orchestra BioMed Holdings
May 13, 2025
Maintains: Buy
Price Target: $20
Current: $3.06
Upside: +553.59%
Korro Bio
May 13, 2025
Maintains: Buy
Price Target: $25
Current: $12.34
Upside: +102.59%
Coya Therapeutics
May 13, 2025
Maintains: Buy
Price Target: $14
Current: $5.89
Upside: +137.69%
Arrowhead Pharmaceuticals
May 13, 2025
Maintains: Buy
Price Target: $60
Current: $16.13
Upside: +271.98%
May 8, 2025
Downgrades: Neutral
Price Target: $1.25 → $6
Current: $9.40
Upside: -36.17%
May 2, 2025
Maintains: Buy
Price Target: $300 → $325
Current: $316.75
Upside: +2.60%
Apr 7, 2025
Maintains: Buy
Price Target: $20
Current: $1.16
Upside: +1,624.14%
Mar 28, 2025
Maintains: Buy
Price Target: $6
Current: $1.93
Upside: +210.88%
Mar 28, 2025
Maintains: Buy
Price Target: $5
Current: $3.19
Upside: +56.74%
Mar 27, 2025
Maintains: Neutral
Price Target: $2.5
Current: $2.50
Upside: -
Mar 14, 2025
Maintains: Buy
Price Target: $4
Current: $2.21
Upside: +81.00%
Nov 13, 2024
Maintains: Buy
Price Target: $10 → $8
Current: $0.98
Upside: +716.33%
Feb 9, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.22
Upside: -
Aug 4, 2023
Maintains: Sell
Price Target: $8 → $6
Current: $10.75
Upside: -44.19%
Nov 10, 2022
Maintains: Buy
Price Target: $60 → $20
Current: $0.47
Upside: +4,118.52%
Nov 9, 2022
Maintains: Buy
Price Target: $65 → $55
Current: $6.77
Upside: +712.41%
Aug 16, 2022
Maintains: Neutral
Price Target: $1.25 → $10
Current: $5.55
Upside: +80.34%
Sep 20, 2021
Upgrades: Neutral
Price Target: $100 → $88
Current: $11.41
Upside: +666.87%
Feb 9, 2021
Downgrades: Neutral
Price Target: $0.7 → $13
Current: $1.05
Upside: +1,138.10%